FI854803A0 - Leukoregulin, antitumoer-lymfokin och dess terapeutiska anvaendning. - Google Patents
Leukoregulin, antitumoer-lymfokin och dess terapeutiska anvaendning.Info
- Publication number
- FI854803A0 FI854803A0 FI854803A FI854803A FI854803A0 FI 854803 A0 FI854803 A0 FI 854803A0 FI 854803 A FI854803 A FI 854803A FI 854803 A FI854803 A FI 854803A FI 854803 A0 FI854803 A0 FI 854803A0
- Authority
- FI
- Finland
- Prior art keywords
- cells
- new
- tumour
- subunit
- patient
- Prior art date
Links
- 108010002060 leukoregulin Proteins 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title 1
- 210000004881 tumor cell Anatomy 0.000 abstract 7
- 210000004027 cell Anatomy 0.000 abstract 6
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 210000004408 hybridoma Anatomy 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 108010001857 Cell Surface Receptors Proteins 0.000 abstract 1
- 102000005348 Neuraminidase Human genes 0.000 abstract 1
- 108010006232 Neuraminidase Proteins 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- 238000005571 anion exchange chromatography Methods 0.000 abstract 1
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 1
- 210000001185 bone marrow Anatomy 0.000 abstract 1
- 210000002798 bone marrow cell Anatomy 0.000 abstract 1
- 230000000711 cancerogenic effect Effects 0.000 abstract 1
- 231100000315 carcinogenic Toxicity 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 230000009089 cytolysis Effects 0.000 abstract 1
- 238000010494 dissociation reaction Methods 0.000 abstract 1
- 230000005593 dissociations Effects 0.000 abstract 1
- 238000001155 isoelectric focusing Methods 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 102000006240 membrane receptors Human genes 0.000 abstract 1
- 210000000822 natural killer cell Anatomy 0.000 abstract 1
- 210000005259 peripheral blood Anatomy 0.000 abstract 1
- 239000011886 peripheral blood Substances 0.000 abstract 1
- 230000035699 permeability Effects 0.000 abstract 1
- 230000035479 physiological effects, processes and functions Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60030384A | 1984-04-13 | 1984-04-13 | |
| US60030384 | 1984-04-13 | ||
| US8500626 | 1985-04-11 | ||
| PCT/US1985/000626 WO1985004662A1 (en) | 1984-04-13 | 1985-04-11 | Leukoregulin, an antitumor lymphokine, and its therapeutic uses |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI854803A0 true FI854803A0 (fi) | 1985-12-04 |
| FI854803L FI854803L (fi) | 1985-12-04 |
| FI85867B FI85867B (fi) | 1992-02-28 |
| FI85867C FI85867C (fi) | 1992-06-10 |
Family
ID=24403068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI854803A FI85867C (fi) | 1984-04-13 | 1985-12-04 | Foerfarande foer framstaellning av ett preparat berikat med en lymfokin kallad leukoregulin. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0179127B1 (fi) |
| JP (2) | JP2562014B2 (fi) |
| AT (1) | ATE48617T1 (fi) |
| AU (2) | AU592529B2 (fi) |
| DE (1) | DE3574710D1 (fi) |
| DK (2) | DK170781B1 (fi) |
| FI (1) | FI85867C (fi) |
| NO (1) | NO170423C (fi) |
| WO (1) | WO1985004662A1 (fi) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE48617T1 (de) * | 1984-04-13 | 1989-12-15 | Litton Bionetics Inc | Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel. |
| US5683688A (en) | 1984-05-31 | 1997-11-04 | Genentech, Inc. | Unglycosylated recombinant human lymphotoxin polypeptides and compositions |
| US6087166A (en) | 1997-07-03 | 2000-07-11 | Basf Aktiengesellschaft | Transcriptional activators with graded transactivation potential |
| EP2029749A2 (en) | 2006-05-15 | 2009-03-04 | Paratek Pharmaceuticals, Inc. | Methods of regulating expression of genes or of gene products using substituted tetracycline compounds |
| EP2710130B1 (en) | 2011-05-19 | 2022-06-29 | Fundación Pública Andaluza Progreso Y Salud | Highly inducible dual-promoter lentiviral tet-on system |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4394448A (en) * | 1978-02-24 | 1983-07-19 | Szoka Jr Francis C | Method of inserting DNA into living cells |
| US4403035A (en) * | 1981-06-19 | 1983-09-06 | Regents Of The University Of Minnesota | In vitro DNA-Protein viral assembly and gene cloning system |
| DE3138230A1 (de) * | 1981-09-25 | 1983-04-07 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Verfahren zur gewinnung von makrophagen- aktivierungsfaktor (maf) |
| JPS6011889B2 (ja) * | 1981-10-28 | 1985-03-28 | 電気化学工業株式会社 | 継代可能なリンホカイン産生ヒトｔ細胞融合株及びその取得方法 |
| US4464465A (en) * | 1982-04-05 | 1984-08-07 | Genetic Systems Corporation | Cell-driven viral transfer in eukaryotes |
| US4443427A (en) * | 1982-06-21 | 1984-04-17 | Sidney Farber Cancer Institute, Inc. | Monoclonal antibody |
| ZA834976B (en) * | 1982-07-30 | 1984-08-29 | Genentech Inc | Human lymphotoxin |
| EP0135797A3 (de) * | 1983-08-30 | 1987-11-11 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Verfahren zur Herstellung von Lymphotoxin und von Lymphotoxin-mRNA |
| ATE48617T1 (de) * | 1984-04-13 | 1989-12-15 | Litton Bionetics Inc | Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel. |
-
1985
- 1985-04-11 AT AT85902248T patent/ATE48617T1/de not_active IP Right Cessation
- 1985-04-11 DE DE8585902248T patent/DE3574710D1/de not_active Expired - Lifetime
- 1985-04-11 AU AU42341/85A patent/AU592529B2/en not_active Ceased
- 1985-04-11 JP JP60501862A patent/JP2562014B2/ja not_active Expired - Lifetime
- 1985-04-11 EP EP85902248A patent/EP0179127B1/en not_active Expired
- 1985-04-11 WO PCT/US1985/000626 patent/WO1985004662A1/en not_active Ceased
- 1985-12-04 DK DK562285A patent/DK170781B1/da active
- 1985-12-04 FI FI854803A patent/FI85867C/fi not_active IP Right Cessation
- 1985-12-12 NO NO85854994A patent/NO170423C/no unknown
-
1990
- 1990-04-18 AU AU53653/90A patent/AU641386B2/en not_active Ceased
-
1992
- 1992-08-04 DK DK098692A patent/DK170423B1/da not_active IP Right Cessation
-
1993
- 1993-11-30 JP JP5300409A patent/JP2564245B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO1985004662A1 (en) | 1985-10-24 |
| FI85867B (fi) | 1992-02-28 |
| DK98692A (da) | 1992-08-04 |
| AU5365390A (en) | 1990-09-20 |
| DE3574710D1 (de) | 1990-01-18 |
| JPH06253832A (ja) | 1994-09-13 |
| NO854994L (no) | 1985-12-12 |
| DK562285D0 (da) | 1985-12-04 |
| AU592529B2 (en) | 1990-01-18 |
| JP2564245B2 (ja) | 1996-12-18 |
| JPS61501853A (ja) | 1986-08-28 |
| EP0179127B1 (en) | 1989-12-13 |
| DK170423B1 (da) | 1995-08-28 |
| AU641386B2 (en) | 1993-09-23 |
| DK170781B1 (da) | 1996-01-15 |
| AU4234185A (en) | 1985-11-01 |
| FI854803L (fi) | 1985-12-04 |
| ATE48617T1 (de) | 1989-12-15 |
| EP0179127A1 (en) | 1986-04-30 |
| NO170423C (no) | 1992-10-14 |
| FI85867C (fi) | 1992-06-10 |
| DK98692D0 (da) | 1992-08-04 |
| NO170423B (no) | 1992-07-06 |
| EP0179127A4 (en) | 1986-08-21 |
| DK562285A (da) | 1985-12-04 |
| JP2562014B2 (ja) | 1996-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chen et al. | A strategy to discover circulating angiogenesis inhibitors generated by human tumors | |
| DK0702563T3 (da) | Sammensætninger og fremgangsmåder til behandling af cancer og hyperproliferative sygdomme | |
| BG43355A3 (en) | Method for preparing of physiologically active polypeptide | |
| CA2202028A1 (en) | Tie-2 ligands, methods of making and uses thereof | |
| HUT70471A (en) | Antitumor imunoconjugates, method for producing them, and pharmaceutical compositions containing the conjugates | |
| WO1996011269B1 (en) | Tie-2 ligands, methods of making and uses thereof | |
| DE3268915D1 (en) | Angiotropins of leukocytes and inflamed tissue: a new class of natural chemotropic protein mitogens for specific induction of directional growth of blood vessels, neovascularization of tissues and morphogenesis of blood vessel patterns, process for their biotechnical preparation and pharmaceutical compositions | |
| DE69332353D1 (de) | Verwendung von inhibitoren der synthese von fettsäuren zur behandlung von krebs | |
| Hopkins et al. | High-frequency cotransfer of the transformed phenotype and a tumor-specific transplantation antigen by DNA from the 3-methylcholanthrene-induced Meth A sarcoma of BALB/c mice. | |
| FI854803A0 (fi) | Leukoregulin, antitumoer-lymfokin och dess terapeutiska anvaendning. | |
| CA2210444A1 (en) | Keratinocyte growth factor-2 | |
| HUT64569A (en) | A process for preparing polypeptide-type compounds usefules for medical treatment of the human body | |
| CN107137424A (zh) | 一种利用正常小鼠建立her2阳性肿瘤的动物模型的方法 | |
| IL99940A0 (en) | Beta-galactoside binding proteins,methods for the production thereof,and pharmaceutical compositions containing the same | |
| AU2001220255A1 (en) | Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferationof cancer cell using the expression vector | |
| SU1173990A1 (ru) | Способ определени активности процесса костеобразовани | |
| Agrez et al. | A fibroblast elongation factor purified from colon carcinoma cells shares sequence identity with TIMP-1 | |
| EP1006125B1 (en) | Goat epididymal forward motility protein | |
| MX9707617A (es) | Factor de crecimiento de criptina humano. | |
| Greenberger et al. | Biochemical Purification of a CSF-1 like Molecule Released during Malignant Transformation of IL-3 Dependent Hematopoietic Progenitor cell lines Cocultivated with Gamma Irradiated Clonal Marrow Stromal cell lines | |
| CN116715734A (zh) | 一种环状多肽及其在制备抗肿瘤药物中的应用 | |
| YAMAOKA et al. | Separation of sarcoma growth inhibitor from avian sarcoma virus-transformed rat cells | |
| CA2269085A1 (en) | Rainbow trout il1.beta.; encoding nucleic acid; materials and methods | |
| Cho | Continuing Education/Psychiatric Nursing-Nursing care for psychiatric patients | |
| Chase | Changes in the maturation of epithelial cells in the mucous membrane of the cheek after therapeutic x-ray radiation in patients with head and neck carcinoma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: AKZO N.V. |